Coreceptor utilization of HIV type 1 subtype E viral isolates from Thai men with HIV type 1-infected and uninfected wives

被引:16
|
作者
Utaipat, U
Duerr, A
Rudolph, DL
Yang, CF
Butera, ST
Lupo, D
Pisell, T
Tangmunkongvorakul, A
Kamtorn, N
Nantachit, N
Nagachinta, T
Suriyanon, V
Robison, V
Nelson, KE
Sittisombut, N
Lal, RB
机构
[1] Ctr Dis Control & Prevent, HIV Immunol & Diagnost Branch, DASTLR, Atlanta, GA USA
[2] Chiang Mai Univ, Fac Med, Dept Med & Microbiol, Chiang Mai 50000, Thailand
[3] Chiang Mai Univ, Fac Med, Res Inst Hlth Sci, Chiang Mai 50000, Thailand
[4] Ctr Dis Control & Prevent, HIV Sect, Womens Hlth & Fertil Branch, Atlanta, GA USA
[5] Ctr Dis Control & Prevent, HIV Retroviruses Dis Branch, DASTLR, Atlanta, GA USA
[6] Chiang Mai Univ Hosp, Blood Bank Serv, Chiang Mai, Thailand
[7] Johns Hopkins Univ, Sch Hyg & Publ Hlth, Dept Epidemiol, Baltimore, MD USA
关键词
D O I
10.1089/088922202753394664
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
HIV-1 coreceptors CCR5 and CXCR4 play an important role in viral entry and pathogenesis. To better understand the role of viral tropism in HIV-1 transmission, we examined the coreceptor utilization of viral isolates obtained from men enrolled in a study of heterosexual transmission in northern Thailand. Viral isolates were obtained from HIV-1-positive males who had either HIV-1-infected spouses (RM; n = 5) or HIV-1-uninfected spouses (HM; n = 10). Viral isolates from 1 of the 5 RM males and 2 of the 10 HM males were CCR5 tropic, whereas isolates from 3 RM males and 6 of the HM male isolates were CXCR4 tropic. Of the nine X4-tropic isolates, seven also used at least one of the following coreceptors: CCR8, CCR1, CCR2b, or CX3CR1, and none employed CCR5 as an additional coreceptor. More importantly, three isolates, RM-15, HM-13, and HM-16 (one from a transmitter and two from nontransmitter), did not infect GHOST4.cl.34 cells expressing any of the known coreceptors. Further analysis using MAGI-plaque assays, which allow visualization of infected cells, revealed that RM-15 had low numbers of infected cells in MAGI-R5 and MAGI-X4 cultures, whereas HM-13 and HM-16 had high levels of plaques in MAGI-X4 cultures. Replication kinetics using activated lymphocytes revealed that these three isolates replicated in CCR5(+/+) as well as CCR5(-/-) peripheral blood mononuclear cells, suggesting that these isolates did not have an absolute requirement of CCR5 for viral entry. All three isolates were sensitive to the X4-antagonistic compounds T-22 and AMD3100. Analysis of the C2V3 region did not reveal any significant structural differences between any of the Thai subtype E isolates. Thus, there was no association between the pattern of coreceptor usage and transmissibility among these subtype E HIV-1 isolates.
引用
收藏
页码:1 / 11
页数:11
相关论文
共 50 条
  • [31] Impact of HIV type 1 subtype variation on viral RNA quantitation
    Parekh, B
    Phillips, S
    Granade, TC
    Baggs, J
    Hu, DJ
    Respess, R
    [J]. AIDS RESEARCH AND HUMAN RETROVIRUSES, 1999, 15 (02) : 133 - 142
  • [32] Management of herpes simplex virus type 2 infection in HIV type 1-infected persons
    Strick, Lara B.
    Wald, Anna
    Celum, Connie
    [J]. CLINICAL INFECTIOUS DISEASES, 2006, 43 (03) : 347 - 356
  • [33] Coreceptor usage of primary HIV type 1 isolates obtained from different lymph node subsets
    Casper, C
    Mild, M
    Jansson, M
    Karlsson, A
    Holmberg, V
    Bratt, G
    van Paaschen, H
    Biberfeld, P
    Björndal, Å
    Albert, J
    Popovic, M
    Fenyö, EM
    [J]. AIDS RESEARCH AND HUMAN RETROVIRUSES, 2005, 21 (12) : 1003 - 1010
  • [34] Evidence of B cell clonal expansion in HIV type 1-infected patients
    Chong, Y
    Ikematsu, H
    Ariyama, I
    Chijiwa, K
    Li, W
    Yamaji, K
    Kashiwagi, S
    Hayashi, J
    [J]. AIDS RESEARCH AND HUMAN RETROVIRUSES, 2001, 17 (16) : 1507 - 1515
  • [35] A Predictive Model for HIV Type 1 Coreceptor Selectivity
    Kieslich, Chris A.
    Shin, David
    Lopez de Victoria, Aliana
    Gonzalez-Rivera, Gloria
    Morikis, Dimitrios
    [J]. AIDS RESEARCH AND HUMAN RETROVIRUSES, 2013, 29 (10) : 1386 - 1394
  • [36] Nigerian HIV type 2 subtype A and B from heterotypic HIV type 1 and HIV type 2 or monotypic HIV type 2 infections
    Zeh, C
    Pieniazek, D
    Agwale, SM
    Robbins, KE
    Odama, L
    Sani-Gwarzo, N
    Gboun, MS
    Inyang, US
    Folks, TM
    Wambebe, C
    Kalish, ML
    [J]. AIDS RESEARCH AND HUMAN RETROVIRUSES, 2005, 21 (01) : 17 - 27
  • [37] HIV type 1 protease inhibitors enhance bone marrow progenitor cell activity in normal subjects and in HIV type 1-infected patients
    Isgrò, A
    Aiuti, A
    Mezzaroma, I
    Ruco, L
    Pinti, M
    Cossarizza, A
    Aiuti, F
    [J]. AIDS RESEARCH AND HUMAN RETROVIRUSES, 2005, 21 (01) : 51 - 57
  • [38] Expression of a novel Nef epitope on the surface of HIV type 1-infected cells
    Yamada, T
    Iwamoto, A
    [J]. AIDS RESEARCH AND HUMAN RETROVIRUSES, 1999, 15 (11) : 1001 - 1009
  • [39] Assessment of type 1 and type 2 cytokines in HIV type 1-infected individuals: Impact of highly active antiretroviral therapy
    Imami, N
    Antonopoulos, C
    Hardy, GAD
    Gazzard, B
    Gotch, FM
    [J]. AIDS RESEARCH AND HUMAN RETROVIRUSES, 1999, 15 (17) : 1499 - 1508
  • [40] Short Communication: Hematological Safety of Perinatal Exposure to Zidovudine in Uninfected Infants Born to HIV Type 1-Infected Women in Thailand
    Briand, Nelly
    Le Coeur, Sophie
    Jourdain, Gonzague
    Hotrawarikarn, Somboon
    Sirinontakan, Surat
    Hinjiranandana, Temsiri
    Kanjanavanit, Suparat
    Traisathit, Patrinee
    McIntosh, Kenneth
    Lallemant, Marc
    [J]. AIDS RESEARCH AND HUMAN RETROVIRUSES, 2010, 26 (10) : 1163 - 1166